Sapporo Higashi Tokushukai Hospital

The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.

Each strip is that field’s whole ranked pool, with the notch where Sapporo Higashi Tokushukai Hospital sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

Where its research is concentrated relative to its size: Surgery takes 8.6× the share of its output that it takes of world research.

1. SurgerySubfield · 22.3 works8.6×

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

• Medicine 4.2×
• Pharmacology, Toxicology and Pharmaceutics 4.1×
• Nursing 1.8×
• Biochemistry, Genetics and Molecular Biology 1.6×
• Immunology and Microbiology 1.5×
• Neuroscience 1.1×
• Health Professions 0.9×
• Dentistry 0.6×
• Chemistry 0.1×
• Engineering 0.1×
• Earth and Planetary Sciences 0.1×
• Environmental Science 0.1×
• Agricultural and Biological Sciences 0.1×
• Physics and Astronomy 0.1×
• Social Sciences 0.1×
• Economics, Econometrics and Finance 0.0×
• Psychology 0.0×

Ranked on the composite score, Toru Kono, Tomoyuki Ohta and Hiroko Murakami lead among researchers whose main affiliation is Sapporo Higashi Tokushukai Hospital.

1. 1 🇯🇵 Toru Kono Japan · #56,340 worldwide 304 citations · 56 works
2. 2 🇯🇵 Tomoyuki Ohta Japan · #756,802 worldwide 11 citations · 23 works
3. 3 🇯🇵 Hiroko Murakami Japan · #829,954 worldwide 51 citations · 21 works
4. 4 🇯🇵 Kiyoshi Iha Japan · #1,305,102 worldwide 5 citations · 18 works

By fractional works in 2022–2025, weighted toward what it does more of than the world: Chemotherapy, Epidemiology, Treatment, Neoadjuvant Therapy, Surgical Management, Complications, Percutaneous Coronary Intervention and Tumor Microenvironment.

By volume in 2022–2025: Pancreatic and Hepatic Oncology Research, Vascular Procedures and Complications, Reconstructive Surgery and Microvascular Techniques and Cardiac Valve Diseases and Treatments.

1. 1 Pancreatic and Hepatic Oncology Research Oncology 4 works
2. 2 Vascular Procedures and Complications Pulmonary and Respiratory Medicine 2 works
3. 3 Reconstructive Surgery and Microvascular Techniques Surgery 2 works
4. 4 Cardiac Valve Diseases and Treatments Cardiology and Cardiovascular Medicine 2 works
5. 5 Cancer Genomics and Diagnostics Cancer Research 2 works
6. 6 Coronary Interventions and Diagnostics Surgery 2 works
7. 7 Infective Endocarditis Diagnosis and Management Epidemiology 2 works
8. 8 Bone fractures and treatments Epidemiology 2 works
9. 9 Inflammatory Bowel Disease Genetics 2 works
10. 10 Peripheral Artery Disease Management Surgery 2 works

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

Output in 2018–2022 was 72% higher than in 2013–2017.

• Hokkaido University
• Sapporo Medical University
• Hokkaido University of Science
• Hokkaido University Hospital
• Hokkaido University of Education
• Hokkaido Pharmaceutical University
• Sapporo University
• Hokkaido Agricultural Research Center